Eli Lilly and Co (NYSE:LLY)
| 255.56 BATS BZX Real-Time Price As of 12:45pm ET |  +8.96 / +3.63%Today’s Change | 129.21 Today|||52-Week Range 259.32 | +51.36% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 246.60 |
| Today’s open | 244.74 |
| Day’s range | 244.14 - 259.32 |
| Volume | 2,521,753 |
| Average volume (3 months) | 3,182,606 |
| Market cap | $233.5B |
Data as of 12:45pm ET, 08/03/2021
Growth & Valuation
| Earnings growth (last year) | +36.99% |
| Earnings growth (this year) | -0.50% |
| Earnings growth (next 5 years) | +13.20% |
| Revenue growth (last year) | +9.95% |
| P/E ratio | 38.3 |
| Price/Sales | 6.28 |
| Price/Book | 41.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +1.17 | +2.66% |
| NVSNovartis | +0.06 | +0.07% |
| ABBVAbbVie | -0.26 | -0.23% |
| MRKMerck | +0.15 | +0.20% |
Data as of 12:46pm ET, 08/03/2021
Financials
| Last reporting date | August 3, 2021 |
| EPS forecast (this quarter) | $1.89 |
| Annual revenue (last year) | $24.5B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 25.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
